首页> 外文期刊>Metabolism: Clinical and Experimental >Comparison of 1-micro g and 250-micro g corticotropin stimulation tests for the evaluation of adrenal function in patients with acquired immunodeficiency syndrome.
【24h】

Comparison of 1-micro g and 250-micro g corticotropin stimulation tests for the evaluation of adrenal function in patients with acquired immunodeficiency syndrome.

机译:比较1微克和250微克的促肾上腺皮质激素刺激试验对获得性免疫缺陷综合症患者肾上腺功能的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Many patients with acquired immunodeficiency syndrome (AIDS) have symptoms suggestive of adrenal insufficiency, but a normal 250- micro g corticotropin (ACTH) stimulation test. We compared the results of 1- micro g and standard 250- micro g ACTH stimulation tests in patients with AIDS. Each patient was studied on 2 separate days. On day 1, 1 micro g ACTH was given intravenously at 8 am after an overnight fast and serum cortisol levels were measured at baseline, and 30 and 60 minutes after ACTH infusion. On day 2, the procedure was repeated with 250- micro g ACTH. An absolute peak cortisol value of > 18 micro g/dL and an increment of 7 micro g/dL or more from baseline constituted a normal response. Among 31 patients, 16 (52%) had discrepant results: 14 (45%) had subnormal responses to 1 micro g ACTH but normal responses to 250 micro g ACTH (group 1); 2 (6%) had normal responses to 1 micro g but subnormal responses to 250 micro g (group 2) ACTH; 6 patients (19%) had concordant abnormal responses (group 3); and 9 (30%) had concordant normal responses (group 4). Eight patients of group 1 underwent a confirmatory insulin tolerance test (ITT); 4 of these patients had abnormal responses to ITT. Kappa statistic and McNemar's test were used to evaluate the data. A kappa statistic value of 0.095 and a P value less than.003 for the McNemar test indicate only random level of agreement and significant differences in the probability of positive result between the 2 ACTH tests. We conclude that discrepancies between the 1- micro g and the 250- micro g ACTH stimulation tests are common in patients with AIDS, with the likelihood of agreement with the "gold standard" ITT of only 50% for each test in our sample of patients. Larger studies are needed to further evaluate the use of these tests in patients with AIDS.
机译:许多患有后天免疫机能丧失综合症(AIDS)的患者都有肾上腺功能不全的症状,但正常的250微克促肾上腺皮质激素(ACTH)刺激试验。我们比较了艾滋病患者1微克和标准250微克ACTH刺激试验的结果。每位患者分别在2天中接受研究。在第1天,禁食过夜后的上午8点静脉注射1微克ACTH,并在基线以及ACTH输注后30和60分钟测量血清皮质醇水平。在第2天,用250微克ACTH重复该过程。皮质醇的绝对峰值> 18 micro g / dL,与基线相比增加7 micro g / dL或更多构成正常反应。在31例患者中,有16例(52%)的结果不一致:14例(45%)的患者对1微克ACTH的反应低于正常,但对250微克ACTH的反应正常(第1组); 2(6%)对1 microg的正常反应,但对250 micro g(2组)的亚正常反应; 6名患者(19%)有一致的异常反应(第3组); 9名(30%)的反应正常(组4)。第一组的八名患者接受了确认胰岛素抵抗测试(ITT)。这些患者中有4例对ITT的反应异常。使用Kappa统计量和McNemar检验来评估数据。 McNemar检验的k统计值为0.095,P值小于0.00,表明2个ACTH检验之间仅一致的随机水平和阳性结果的概率存在显着差异。我们得出结论,在艾滋病患者中,1克微克和250克微克ACTH刺激测试之间存在差异,在我们的患者样本中,每次测试的“黄金标准” ITT可能只有50%一致。需要更大的研究来进一步评估这些测试在艾滋病患者中的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号